Profile data is unavailable for this security.
About the company
Masimo Corporation is a global technology company that develops and produces a range of monitoring technologies, including measurements, sensors, patient monitors, and automation and connectivity solutions. The Company's segments include Healthcare and Non-healthcare. Its Healthcare segment develops, manufactures and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. The Company's measurement technologies include Measure-through Motion and Low Perfusion pulse oximetry and advanced rainbow Pulse CO-Oximetry parameters. The Company's Non-healthcare business develops, manufactures, markets, sells home sound integration technologies and accessories, along with licensing complete high performance in-vehicle audio systems under consumer brands, such as Bowers & Wilkins, Denon, Marantz, HEOS, Classe, Polk Audio, Boston Acoustics, and Definitive Technology.
- Revenue in USD (TTM)1.98bn
- Net income in USD79.10m
- Incorporated1996
- Employees3.80k
- LocationMasimo Corp52 DiscoveryIRVINE 92618United StatesUSA
- Phone+1 (949) 297-7000
- Fax+1 (949) 297-7499
- Websitehttps://www.masimo.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Inari Medical Inc | 520.66m | -23.62m | 3.41bn | 1.30k | -- | 7.60 | -- | 6.55 | -0.409 | -0.409 | 8.95 | 7.71 | 0.8913 | 1.58 | 7.75 | 400,506.90 | -4.04 | -0.5941 | -4.57 | -0.6696 | 87.67 | 89.06 | -4.54 | -0.6295 | 2.19 | -- | 0.00 | -- | 28.73 | 135.40 | 94.41 | -- | 52.46 | -- |
Axonics Inc | 387.14m | -15.95m | 3.47bn | 797.00 | -- | 5.53 | -- | 8.96 | -0.3134 | -0.3134 | 7.76 | 12.29 | 0.5606 | 1.20 | 8.53 | 485,744.00 | -2.31 | -12.67 | -2.52 | -13.76 | 75.25 | 70.04 | -4.12 | -29.68 | 8.04 | -- | 0.00 | -- | 33.86 | 249.06 | 89.80 | -- | 23.65 | -- |
Procept Biorobotics Corp | 156.33m | -103.37m | 3.66bn | 626.00 | -- | 13.86 | -- | 23.43 | -2.12 | -2.12 | 3.20 | 5.14 | 0.4685 | 1.81 | 4.08 | 249,722.00 | -30.98 | -- | -34.68 | -- | 53.47 | -- | -66.12 | -- | 7.44 | -- | 0.1629 | -- | 81.55 | -- | -21.51 | -- | -- | -- |
Neogen Corp | 929.24m | 1.57m | 3.81bn | 2.64k | 2,436.89 | 1.21 | 32.29 | 4.10 | 0.0072 | 0.0072 | 4.29 | 14.52 | 0.2044 | 2.79 | 5.81 | 351,984.10 | 0.0345 | 3.44 | 0.0355 | 3.62 | 50.97 | 47.25 | 0.1685 | 7.77 | 2.66 | 1.37 | 0.2205 | 0.00 | 56.01 | 15.63 | -147.34 | -- | 25.71 | -- |
Integer Holdings Corp | 1.63bn | 98.09m | 4.17bn | 10.50k | 43.19 | 2.73 | 20.94 | 2.55 | 2.88 | 2.88 | 47.86 | 45.52 | 0.5452 | 4.91 | 4.95 | 155,494.60 | 3.28 | 3.28 | 3.53 | 3.53 | 26.54 | 26.94 | 6.01 | 6.40 | 2.01 | 3.74 | 0.4303 | 0.00 | 16.03 | 5.62 | 38.71 | 9.33 | 21.71 | -- |
Inspire Medical Systems Inc | 660.91m | -15.73m | 4.32bn | 1.01k | -- | 7.33 | -- | 6.54 | -0.5374 | -0.5374 | 22.46 | 19.85 | 1.05 | 3.14 | 10.01 | 653,721.10 | -2.50 | -11.27 | -2.80 | -12.60 | 84.65 | 84.47 | -2.38 | -13.57 | 7.25 | -- | 0.00 | -- | 53.19 | 65.32 | 52.87 | -- | 148.37 | -- |
Haemonetics Corporation | 1.31bn | 117.56m | 4.60bn | 3.66k | 39.51 | 4.78 | 21.40 | 3.51 | 2.29 | 2.29 | 25.47 | 18.90 | 0.6339 | 2.10 | 6.79 | 357,958.70 | 5.69 | 5.02 | 6.57 | 6.07 | 53.69 | 51.74 | 8.98 | 8.11 | 1.50 | 18.09 | 0.457 | 0.00 | 12.01 | 6.23 | 1.87 | 16.40 | -11.04 | -- |
TransMedics Group Inc | 296.92m | -10.20m | 4.92bn | 584.00 | -- | 30.74 | 4,488.80 | 16.55 | -0.335 | -0.335 | 8.96 | 4.85 | 0.5874 | 3.08 | 4.93 | 508,422.90 | -2.02 | -16.08 | -2.19 | -17.95 | 62.40 | 65.37 | -3.43 | -40.47 | 8.76 | -- | 0.7607 | -- | 158.53 | 79.36 | 30.92 | -- | 225.12 | -- |
Merit Medical Systems Inc | 1.28bn | 101.95m | 5.03bn | 6.95k | 49.67 | 4.06 | 25.82 | 3.92 | 1.74 | 1.74 | 21.96 | 21.35 | 0.64 | 2.32 | 7.32 | 184,648.80 | 5.08 | 2.45 | 5.65 | 2.77 | 46.54 | 44.50 | 7.94 | 3.91 | 4.38 | 11.74 | 0.3922 | 0.00 | 9.24 | 7.33 | 26.70 | 15.86 | -11.16 | -- |
DENTSPLY SIRONA Inc | 3.94bn | -95.00m | 5.72bn | 15.00k | -- | 1.75 | 22.60 | 1.45 | -0.4468 | -0.4468 | 18.69 | 15.69 | 0.5326 | 2.94 | 6.02 | 262,666.70 | -1.24 | -1.14 | -1.52 | -1.32 | 52.61 | 53.65 | -2.34 | -2.51 | 0.9692 | 3.27 | 0.3908 | -- | 1.10 | -0.1071 | 86.11 | -- | -4.54 | 9.86 |
Masimo Corp | 1.98bn | 79.10m | 5.80bn | 3.80k | 74.43 | 4.24 | 33.02 | 2.93 | 1.46 | 1.46 | 36.54 | 25.71 | 0.6507 | 2.01 | 5.24 | 519,973.70 | 2.60 | 8.65 | 3.17 | 10.31 | 48.61 | 57.30 | 4.00 | 12.03 | 1.31 | 3.61 | 0.3909 | 0.00 | 0.6042 | 19.00 | -43.21 | -15.96 | 31.06 | -- |
Glaukos Corp | 326.43m | -140.87m | 6.25bn | 907.00 | -- | 13.73 | -- | 19.16 | -2.88 | -2.88 | 6.68 | 9.04 | 0.3426 | 1.72 | 7.74 | 359,905.20 | -14.78 | -8.73 | -15.91 | -9.35 | 76.18 | 74.77 | -43.16 | -28.69 | 4.68 | -38.38 | 0.4395 | -- | 11.26 | 11.66 | -35.75 | -- | 14.44 | -- |
Stevanato Group SpA | 1.18bn | 148.92m | 6.54bn | 5.64k | 38.59 | -- | 33.70 | 5.52 | 0.5616 | 0.5616 | 4.46 | -- | -- | -- | -- | 210,269.70 | -- | -- | -- | -- | 30.81 | -- | 12.57 | -- | -- | 32.91 | -- | -- | 10.34 | -- | 1.95 | -- | -- | -- |
Repligen Corp | 607.45m | 14.84m | 7.39bn | 1.78k | 524.17 | 3.75 | 87.53 | 12.17 | 0.2524 | 0.2524 | 10.74 | 35.29 | 0.2255 | 1.43 | 4.87 | 340,689.80 | 0.551 | 4.38 | 0.6179 | 5.03 | 47.73 | 55.43 | 2.44 | 15.91 | 5.24 | -- | 0.2284 | 0.00 | -20.31 | 26.91 | -77.64 | 20.13 | 24.99 | -- |
Penumbra Inc | 1.10bn | 93.39m | 7.88bn | 4.20k | 85.50 | 6.54 | 64.79 | 7.19 | 2.38 | 2.38 | 27.90 | 31.05 | 0.7366 | 1.03 | 5.49 | 260,899.80 | 6.28 | 2.32 | 6.98 | 2.61 | 65.04 | 63.90 | 8.52 | 3.17 | 3.51 | -- | 0.0207 | 0.00 | 24.95 | 18.93 | 4,643.16 | 68.60 | 9.64 | -- |
Holder | Shares | % Held |
---|---|---|
Fidelity Management & Research Co. LLCas of 31 Mar 2024 | 6.20m | 11.66% |
Politan Capital Management LPas of 17 Jul 2024 | 4.71m | 8.86% |
The Vanguard Group, Inc.as of 31 Mar 2024 | 4.49m | 8.44% |
BlackRock Fund Advisorsas of 31 Mar 2024 | 4.01m | 7.54% |
Capital Research & Management Co. (Global Investors)as of 31 Mar 2024 | 2.27m | 4.27% |
BlackRock Investment Management (UK) Ltd.as of 31 Mar 2024 | 1.88m | 3.54% |
Massachusetts Financial Services Co.as of 31 Mar 2024 | 1.72m | 3.24% |
Farallon Capital Management LLCas of 31 Mar 2024 | 1.49m | 2.80% |
RTW Investments LPas of 31 Mar 2024 | 1.46m | 2.75% |
SSgA Funds Management, Inc.as of 31 Mar 2024 | 1.36m | 2.56% |